Cargando…
Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy
PURPOSE: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT). METHODS: Total of 201 VMAT plans with measur...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334519/ https://www.ncbi.nlm.nih.gov/pubmed/37434171 http://dx.doi.org/10.1186/s13014-023-02311-7 |
_version_ | 1785070872904597504 |
---|---|
author | Han, Ce Zhang, Ji Yu, Bing Zheng, Haoze Wu, Yibo Lin, Zhixi Ning, Boda Yi, Jinling Xie, Congying Jin, Xiance |
author_facet | Han, Ce Zhang, Ji Yu, Bing Zheng, Haoze Wu, Yibo Lin, Zhixi Ning, Boda Yi, Jinling Xie, Congying Jin, Xiance |
author_sort | Han, Ce |
collection | PubMed |
description | PURPOSE: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT). METHODS: Total of 201 VMAT plans with measured PSQA results were retrospectively enrolled and divided into training and testing sets randomly at 7:3. PC metrics were calculated using house-built algorithm based on Matlab. Dosiomics features were extracted and selected using Random Forest (RF) from planning target volume (PTV) and overlap regions with 3D dose distributions. The top 50 dosiomics and 5 PC features were selected based on feature importance screening. A DL DenseNet was adapted and trained for the PSQA prediction. RESULTS: The measured average gamma passing rate (GPR) of these VMAT plans was 97.94% ± 1.87%, 94.33% ± 3.22%, and 87.27% ± 4.81% at the criteria of 3%/3 mm, 3%/2 mm, and 2%/2 mm, respectively. Models with PC features alone demonstrated the lowest area under curve (AUC). The AUC and sensitivity of PC and dosiomics (D) combined model at 2%/2 mm were 0.915 and 0.833, respectively. The AUCs of DL models were improved from 0.943, 0.849, 0.841 to 0.948, 0.890, 0.942 in the combined models (PC + D + DL) at 3%/3 mm, 3%/2 mm and 2%/2 mm, respectively. A best AUC of 0.942 with a sensitivity, specificity and accuracy of 100%, 81.8%, and 83.6% was achieved with combined model (PC + D + DL) at 2%/2 mm. CONCLUSIONS: Integrating DL with dosiomics and PC metrics is promising in the prediction of GPRs in PSQA for patients underwent VMAT. |
format | Online Article Text |
id | pubmed-10334519 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103345192023-07-12 Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy Han, Ce Zhang, Ji Yu, Bing Zheng, Haoze Wu, Yibo Lin, Zhixi Ning, Boda Yi, Jinling Xie, Congying Jin, Xiance Radiat Oncol Research PURPOSE: To investigate the feasibility and performance of deep learning (DL) models combined with plan complexity (PC) and dosiomics features in the patient-specific quality assurance (PSQA) for patients underwent volumetric modulated arc therapy (VMAT). METHODS: Total of 201 VMAT plans with measured PSQA results were retrospectively enrolled and divided into training and testing sets randomly at 7:3. PC metrics were calculated using house-built algorithm based on Matlab. Dosiomics features were extracted and selected using Random Forest (RF) from planning target volume (PTV) and overlap regions with 3D dose distributions. The top 50 dosiomics and 5 PC features were selected based on feature importance screening. A DL DenseNet was adapted and trained for the PSQA prediction. RESULTS: The measured average gamma passing rate (GPR) of these VMAT plans was 97.94% ± 1.87%, 94.33% ± 3.22%, and 87.27% ± 4.81% at the criteria of 3%/3 mm, 3%/2 mm, and 2%/2 mm, respectively. Models with PC features alone demonstrated the lowest area under curve (AUC). The AUC and sensitivity of PC and dosiomics (D) combined model at 2%/2 mm were 0.915 and 0.833, respectively. The AUCs of DL models were improved from 0.943, 0.849, 0.841 to 0.948, 0.890, 0.942 in the combined models (PC + D + DL) at 3%/3 mm, 3%/2 mm and 2%/2 mm, respectively. A best AUC of 0.942 with a sensitivity, specificity and accuracy of 100%, 81.8%, and 83.6% was achieved with combined model (PC + D + DL) at 2%/2 mm. CONCLUSIONS: Integrating DL with dosiomics and PC metrics is promising in the prediction of GPRs in PSQA for patients underwent VMAT. BioMed Central 2023-07-11 /pmc/articles/PMC10334519/ /pubmed/37434171 http://dx.doi.org/10.1186/s13014-023-02311-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Han, Ce Zhang, Ji Yu, Bing Zheng, Haoze Wu, Yibo Lin, Zhixi Ning, Boda Yi, Jinling Xie, Congying Jin, Xiance Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
title | Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
title_full | Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
title_fullStr | Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
title_full_unstemmed | Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
title_short | Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
title_sort | integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334519/ https://www.ncbi.nlm.nih.gov/pubmed/37434171 http://dx.doi.org/10.1186/s13014-023-02311-7 |
work_keys_str_mv | AT hance integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT zhangji integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT yubing integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT zhenghaoze integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT wuyibo integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT linzhixi integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT ningboda integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT yijinling integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT xiecongying integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy AT jinxiance integratingplancomplexityanddosiomicsfeatureswithdeeplearninginpatientspecificqualityassuranceforvolumetricmodulatedarctherapy |